Explore more publications!
Healthcare Times Guadeloupe
Got News to Share?

Healthcare Times Guadeloupe: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Times Guadeloupe.

February 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

Press releases published on March 26, 2026

NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES / ISSUANCE OF A NEW SUBSCRIPTION REQUEST NOTICE UNDER THE SHARE SUBSCRIPTION FACILITY AGREEMENT WITH GEM
Mar. 26, 2026

NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES / ISSUANCE OF A NEW SUBSCRIPTION REQUEST NOTICE UNDER THE SHARE SUBSCRIPTION FACILITY AGREEMENT WITH GEM

Indeterminate GlobeNewswire
Neuroprotective Agents Market to Reach $60.9 Billion by 2030 as Neurological Disease Burden and Aging Populations Drive Pharmaceutical Investment
Mar. 26, 2026

Neuroprotective Agents Market to Reach $60.9 Billion by 2030 as Neurological Disease Burden and Aging Populations Drive Pharmaceutical Investment

Indeterminate GlobeNewswire
Wake Radiology Chief Operating Officer Parul Galloway Receives 2026 Women in Business Award by the Triangle Business Journal
Mar. 26, 2026

Wake Radiology Chief Operating Officer Parul Galloway Receives 2026 Women in Business Award by the Triangle Business Journal

Indeterminate GlobeNewswire
Valneva to Participate in Multiple Events at the 26th World Vaccine Congress in Washington DC
Mar. 26, 2026

Valneva to Participate in Multiple Events at the 26th World Vaccine Congress in Washington DC

Indeterminate GlobeNewswire
Valneva participera à plusieurs événements lors du 25ème World Vaccine Congress de Washington
Mar. 26, 2026

Valneva participera à plusieurs événements lors du 25ème World Vaccine Congress de Washington

Indeterminate GlobeNewswire
Tevogen Advances Strategic CRO Evaluation to Expand Clinical Research Delivery Capabilities and Drive Revenue Growth
Mar. 26, 2026

Tevogen Advances Strategic CRO Evaluation to Expand Clinical Research Delivery Capabilities and Drive Revenue Growth

Indeterminate GlobeNewswire
Resolutions from Zealand Pharma's Annual General Meeting 2026
Mar. 26, 2026

Resolutions from Zealand Pharma's Annual General Meeting 2026

Indeterminate GlobeNewswire
Bigelow Tea Sources Premium Ingredients from Farms and Growers Around the World
Mar. 26, 2026

Bigelow Tea Sources Premium Ingredients from Farms and Growers Around the World

Indeterminate GlobeNewswire
ProFeel Life Establishes Itself as Switzerland's Specialist in Additive-Free Dietary Supplements
Mar. 26, 2026

ProFeel Life Establishes Itself as Switzerland's Specialist in Additive-Free Dietary Supplements

Indeterminate GlobeNewswire
Nucleus Brings Genetic Optimization to India and the Middle East Through Leading IVF Networks
Mar. 26, 2026

Nucleus Brings Genetic Optimization to India and the Middle East Through Leading IVF Networks

Indeterminate GlobeNewswire
Nucleus מביאה אופטימיזציה גנטית להודו ולמזרח התיכון באמצעות רשתות IVF מובילות
Mar. 26, 2026

Nucleus מביאה אופטימיזציה גנטית להודו ולמזרח התיכון באמצעות רשתות IVF מובילות

Indeterminate GlobeNewswire
My Vaccine Lawyer Secures $315,000 Settlement for Guillain-Barré Syndrome Case
Mar. 26, 2026

My Vaccine Lawyer Secures $315,000 Settlement for Guillain-Barré Syndrome Case

Indeterminate GlobeNewswire
SK pharmteco to Host Innovations in Pharmaceutical Manufacturing Symposium in Cambridge, Massachusetts
Mar. 26, 2026

SK pharmteco to Host Innovations in Pharmaceutical Manufacturing Symposium in Cambridge, Massachusetts

Indeterminate GlobeNewswire
Can-Fite Reports 2025 Financial Results and Ongoing Clinical Progress Highlighting Positive Data in Phase 2a Pancreatic cancer and 9 Years Cancer-Free Survival in Liver Cancer Patient
Mar. 26, 2026

Can-Fite Reports 2025 Financial Results and Ongoing Clinical Progress Highlighting Positive Data in Phase 2a Pancreatic cancer and 9 Years Cancer-Free Survival in Liver Cancer Patient

Indeterminate GlobeNewswire
更正 -- 維泰瑞隆宣佈委任王舒展先生為董事會董事
Mar. 26, 2026

更正 -- 維泰瑞隆宣佈委任王舒展先生為董事會董事

Indeterminate GlobeNewswire
更正 -- 维泰瑞隆宣布委任王舒展先生为董事会董事
Mar. 26, 2026

更正 -- 维泰瑞隆宣布委任王舒展先生为董事会董事

Indeterminate GlobeNewswire
Polyrizon Provides 2025 and Recent Highlights
Mar. 26, 2026

Polyrizon Provides 2025 and Recent Highlights

Indeterminate GlobeNewswire
Edesa Biotech Advances Vitiligo Program for Planned Mid-2026 Enrollment
Mar. 26, 2026

Edesa Biotech Advances Vitiligo Program for Planned Mid-2026 Enrollment

Indeterminate GlobeNewswire
Neion Bio Emerges from Stealth with Multi-Product Biosimilar Partnership Leveraging Its Cutting-Edge Genetic Engineering Platform
Mar. 26, 2026

Neion Bio Emerges from Stealth with Multi-Product Biosimilar Partnership Leveraging Its Cutting-Edge Genetic Engineering Platform

Indeterminate GlobeNewswire
FDA clears Philips AI solution that provides real-time guidance during complex minimally invasive heart valve repair
Mar. 26, 2026

FDA clears Philips AI solution that provides real-time guidance during complex minimally invasive heart valve repair

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions